March 13, 2008 - The Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA), commended the FDA for initiating an expert panel to investigate issues regarding CAD and permitting public input on the importance of CAD submissions to the FDA and the benefits of CAD.
Those participating discussed CAD devices for the lung, colon and breast and reviewed both the clinical value of these devices and the scientific data for obtaining FDA approval or clearance. MITA agrees with the panel’s recommendation to seek out the least burdensome approach to effective compliance and stand ready to work with the FDA and propose peer-reviewed testing methodologies.
For more information: www.nema.org